Concerns about the potential side effects of Ortho Evra have risen steadily in the five years since the patch came on the market. In July 2005, one study revealed that women using Ortho Evra patch are three times more likely to experience blood clots than women who use birth control pills.
As result, the Food and Drug Administration forced Ortho-McNeil, the manufacturer of the birth control patch, to strengthen consumer warnings about the risk of Ortho Evra side effects. A "black-box" warning was added to the labeling in order to alert consumers and their doctors about the risks posed by the Ortho Evra birth control patch.
Despite these warnings, at least 23 women died as a result of side effects they suffered while using the Patch, and at least 17 of these deaths were the result of blood clots. Hundreds more women have suffered blood clots, heart attacks, pulmonary embolisms or strokes after using the patch.
The reason that the risk of blood clots and other side effects is so much higher in the Ortho Evra Patch compared with the pill has to do with the way the two products release hormones into the body. Both work by releasing a combination of estrogen and progestin into the blood stream in order to prevent ovulation. But because the hormones in the Ortho Evra patch pass directly into the blood stream, women using the device receive a 60% higher dose of estrogen that users of the pill. Because estrogen can cause blood to clot, this places users in danger of suffering serious and potentially deadly Ortho Evra side effects.
READ MORE LEGAL NEWS
Despite evidence linking the Ortho Evra patch to cases of blood clots, heart attack, pulmonary embolism, stroke and even death, neither the FDA nor its manufacturer, Ortho-McNeil, have called for an Ortho Evra recall. Regardless, many women who were injured after using the patch have filed Ortho Evra lawsuits against the company, alleging that it failed to warn them about the dangers they faced from using the Patch.